|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03157921 |
|
Date of registration:
|
16/05/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Prevalence of Pregnancy in Polycystic Ovary Syndrome
|
|
Scientific title:
|
Prevalence of Spontaneous Ovulation and Pregnancy in Patients With Polycystic Ovary Syndrome |
|
Date of first enrolment:
|
April 2016 |
|
Target sample size:
|
70 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03157921 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- infertile women
- age from 18 to 40 years
- poly-cystic ovary syndrome
- Body mass index 18.5-35 kg/m2
Exclusion Criteria:
1. Endocrine disorders (cushing syndrome-congenital adrenal hyperplasia)
2. Systemic disease
3. Use of oral contraceptive,glucocorticoid and antiandrogen
4. Use of ovulation induction or dopaminergic agents
5. Use of antidiabetes, anti obesity drugs
6. history of tubal or ovarian surgery
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Polycystic Ovary Syndrome
|
|
Intervention(s)
|
|
Diagnostic Test: Hormonal levels
|
|
Radiation: transvaginal ultrasound
|
|
Primary Outcome(s)
|
|
Number of poly-cystic ovarian syndrome women who will be ovulated
[Time Frame: 3 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|